Cargando…

The prognostic significance of hematogones and CD34+ myeloblasts in bone marrow for adult B-cell lymphoblastic leukemia without minimal residual disease

This study was aimed to dissect the prognostic significances of hematogones and CD34+ myeloblasts in bone marrow for adult B-cell acute lymphoblastic leukemia(ALL) without minimal residual disease(MRD) after the induction chemotherapy cycle. A total of 113 ALL patients who have received standardized...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liao, Hongyan, Zheng, Qin, Jin, Yongmei, Chozom, Tashi, Zhu, Ying, Liu, Li, Jiang, Nenggang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6928064/ https://www.ncbi.nlm.nih.gov/pubmed/31871314 http://dx.doi.org/10.1038/s41598-019-56126-2

Ejemplares similares

Hematogones: The Supreme Mimicker and a Cytomorphological Confounder in Acute Lymphoblastic Leukemia
por: Singh, Kanwaljeet, et al.
Publicado: (2022)

Hematogones in patients with acute myeloid leukaemia: Prognostic value and correlation with minimal residual disease
por: Tavarozzi, Rita, et al.
Publicado: (2021)

PB1753: EVALUATION OF IMMUNOPHENOTYPIC CHARACTERISTICS OF RESIDUAL CELLS IN COMPARISON WITH NORMAL HEMATOGONES AND MATURE CELLS IN CHILDREN WITH B-CELL LYMPHOBLASTIC LEUKEMIA
por: Karnabeda, Oksana, et al.
Publicado: (2023)

The Presence of Precursors of Benign Pre-B Lymphoblasts (Hematogones) in the Bone Marrow of a Paediatric Patient with Cytomegalovirus Infection
por: Moreno-Madrid, F, et al.
Publicado: (2008)

Observations on hematogones with light chain restriction.
por: D'Ardia, Angela, et al.
Publicado: (2022)

Concomitant T-cell prolymphocytic leukemia and visceral leishmaniasis: A case report
por: Liao, Hongyan, et al.
Publicado: (2018)

Minimal Residual Disease Detection in Acute Lymphoblastic Leukemia
por: Kruse, Aaron, et al.
Publicado: (2020)

MLL rearrangements in pediatric acute lymphoblastic and myeloblastic leukemias: MLL specific and lineage specific signatures
por: Zangrando, Andrea, et al.
Publicado: (2009)

Differential cytogenetic profile in advanced chronic myeloid leukemia with sequential lymphoblastic and myeloblastic blast crisis()
por: Calderón-Cabrera, C., et al.
Publicado: (2013)

Cytomegalovirus keratitis in acute myeloblastic leukemia
por: Daryabari, Seyed-Hashem, et al.
Publicado: (2023)

B-cell precursors (hematogones) in CD34+ hematopoietic stem cell collections: a single-center experience
por: Matos, Daniel Mazza
Publicado: (2022)

Clinical Significance of Minimal Residual Disease at the End of Remission Induction Therapy in Childhood Acute Lymphoblastic Leukemia
por: Jovanovska, Aleksandra, et al.
Publicado: (2019)

Increased hematogones in an infant with bicytopenia and leucocytosis:a case report
por: Agarwal, Kiran, et al.
Publicado: (2010)

Prognostic Significance and Treatment Implications of Minimal Residual Disease Studies in Philadelphia-Negative Adult Acute Lymphoblastic Leukemia
por: Spinelli, Orietta, et al.
Publicado: (2014)

Minimal Residual Disease in Acute Lymphoblastic Leukemia: Technical and Clinical Advances
por: Della Starza, Irene, et al.
Publicado: (2019)

Minimal Residual Disease in Adult Acute Lymphoblastic Leukemia: Egyptian Experience
por: Ibrahim, Rasha Ibrahim, et al.
Publicado: (2022)

Expression of the p53 oncogene in acute myeloblastic leukemia
Publicado: (1986)

Actual biological diagnosis of acute myeloblastic leukemia in children
por: Buga Corbu, V, et al.
Publicado: (2014)

Medullary allotransplant in acute myeloblastic leukemia in a child
por: Buga Corbu, V, et al.
Publicado: (2014)

Pseudo-Kappa Light Chain Restricted Hematogones in Patients Receiving Daratumumab
por: Tariq, Hamza, et al.
Publicado: (2022)

Current Strategies for the Detection of Minimal Residual Disease in Childhood Acute Lymphoblastic Leukemia
por: Rocha, Juliana Maria Camargos, et al.
Publicado: (2016)

Sources of error in measurement of minimal residual disease in childhood acute lymphoblastic leukemia
por: Latham, Sue, et al.
Publicado: (2017)

Minimal Residual Disease in Acute Lymphoblastic Leukemia: Current Practice and Future Directions
por: Contreras Yametti, Gloria Paz, et al.
Publicado: (2021)

Optimizing Molecular Minimal Residual Disease Analysis in Adult Acute Lymphoblastic Leukemia
por: Della Starza, Irene, et al.
Publicado: (2023)

T cell receptor and immunoglobulin gene rearrangements in acute myeloblastic leukemia
Publicado: (1986)

Acute acalculous cholecystitis complicating chemotherapy for acute myeloblastic leukemia
por: Kassar, Olfa, et al.
Publicado: (2015)

The utility of multiparametric flow cytometry for the detection of minimal residual disease in acute lymphoblastic leukemia
por: Cunha, Fernanda Gonçalves Pereira, et al.
Publicado: (2012)

Minimal residual disease in acute lymphoblastic leukemia: technical aspects and implications for clinical interpretation
por: Kim, In-Suk
Publicado: (2020)

Circulating microRNAs as minimal residual disease biomarkers in childhood acute lymphoblastic leukemia
por: Rzepiel, Andrea, et al.
Publicado: (2019)

Multiparameter Flow Cytometry to Detect Hematogones and to Assess B-lymphocyte clonality in Bone Marrow Samples from Patients with Non-Hodgkin Lymphomas
por: Carulli, Giovanni, et al.
Publicado: (2014)

HISTOCHEMISTRY OF THE CENTRIOLES AND CENTROSOMES OF THE LEUKEMIC CELLS FROM HUMAN MYELOBLASTIC LEUKEMIA
por: Ackerman, G. Adolph
Publicado: (1961)

The microRNAs involved in human myeloid differentiation and myelogenous/myeloblastic leukemia
por: Wang, Xiao-Shuang, et al.
Publicado: (2008)

Lapatinib induces autophagic cell death and differentiation in acute myeloblastic leukemia
por: Chen, Yu-Jen, et al.
Publicado: (2016)

Transcriptome Analysis of Minimal Residual Disease in Subtypes of Pediatric B Cell Acute Lymphoblastic Leukemia
por: Sitthi-amorn, Jitsuda, et al.
Publicado: (2015)

Proposal for the standardization of flow cytometry protocols to detect minimal residual disease in acute lymphoblastic leukemia
por: Ikoma, Maura Rosane Valério, et al.
Publicado: (2015)

Genotype-Specific Minimal Residual Disease Interpretation Improves Stratification in Pediatric Acute Lymphoblastic Leukemia
por: O’Connor, David, et al.
Publicado: (2018)

Testing for minimal residual disease in adults with acute lymphoblastic leukemia in Europe: a clinician survey
por: Pigneux, Arnaud, et al.
Publicado: (2018)

Minimal residual disease in childhood B Lymphoblastic Leukemia and its correlation with other risk factors
por: Meraj, Fatima, et al.
Publicado: (2020)

Frequency of 11q23/MLL gene rearrangement in Egyptian childhood acute myeloblastic leukemia: Biologic and clinical significance
por: Hagag, Adel Abdelhaleim, et al.
Publicado: (2014)

When Less Is Good, Is None Better? The Prognostic and Therapeutic Significance of Peri-Transplant Minimal Residual Disease Assessment in Pediatric Acute Lymphoblastic Leukemia
por: Lamble, Adam, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_it8m88jtmkqnvovle4litf0qp0